Single nucleotide polymorphisms in the mitochondrial displacement loop region modifies malignant melanoma: a study in

Wenjin Zhang1, Wei Wang, Zhifeng Jia

  • 1Department of Breast Surgery .

Mitochondrial DNA
|March 26, 2014
PubMed

Insights

Single nucleotide polymorphisms (SNPs) in mitochondrial DNA (mtDNA) D-loop may increase malignant melanoma (MM) risk. Specific SNPs (T16362C, A16399G, T195C) were linked to higher MM susceptibility in the Chinese Han population.

Area of Science:

  • Genetics
  • Oncology
  • Mitochondrial DNA research

Background:

  • Single nucleotide polymorphisms (SNPs) in mitochondrial DNA (mtDNA) are implicated in various diseases.
  • The displacement loop (D-loop) of mtDNA is a critical regulatory region prone to mutations.
  • Malignant melanoma (MM) is a significant public health concern with complex genetic underpinnings.

Purpose of the Study:

  • To investigate the association between D-loop SNPs and MM risk in the Chinese Han population.
  • To identify specific D-loop genetic variants that may confer susceptibility to MM.
  • To explore the potential of D-loop SNP analysis for risk stratification in MM.

Main Methods:

  • A case-controlled study design was employed.
  • Genotyping of D-loop SNPs was performed in MM patients and healthy controls.
  • Statistical analysis was used to compare SNP frequencies between cases and controls.

Main Results:

  • A statistically significant increase in the frequency of T16362C, A16399G, and T195C alleles was observed in MM patients compared to controls (p < 0.05).
  • These specific D-loop SNPs were associated with an increased susceptibility to MM in the studied population.
  • The findings suggest a correlation between mitochondrial D-loop genetic variations and MM risk.

Conclusions:

  • SNPs in the mitochondrial D-loop are associated with an increased risk of developing MM in the Chinese Han population.
  • Identifying individuals with these specific D-loop SNPs could aid in early risk assessment for MM.
  • This genetic analysis may inform personalized therapeutic strategies for high-risk MM patient subgroups.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.4K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.4K